Developer docs
API playgroundTry for free, no card

Search company profiles

PharmaCann

Full company profile

uuid0000hhb

Namestring
PharmaCann
Legal namestring
PharmaCann Inc.
Websiteurl
pharmacann.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

PharmaCann is a Chicago-headquartered, vertically integrated cannabis operator founded in 2014, running two complementary go-to-market engines: a direct-to-consumer retail dispensary network under the Verilife brand (Illinois, Maryland, Massachusetts, New York, Ohio, Pennsylvania) and the LivWell brand (Colorado, Michigan), alongside a B2B wholesale channel that distributes its house of brands—P3 (infused pre-rolls), matter. (full product line), Magnitude (distillate vapes), #HASH (concentrates), Full Melt (edibles), CAM (premium flower), PC Nursery (small-batch flower), and LivWell—to third-party dispensaries through LeafLink and Leaf Trade platforms.

Core operations span cannabis cultivation, processing, and retail across eight U.S. states, with internal production facilities including a Hamptonburgh, New York cultivation site. The company's house-of-brands architecture targets distinct price points, potency levels, and consumption formats—from premium CAM flower to the lower-potency matter.lite line for newer consumers—while a social equity program (Mission Green Alliance, round-up donations) functions as a non-product differentiator.

Revenue is generated primarily through retail transaction fees at company-owned dispensaries and wholesale distribution to third-party retailers. Following the February 2022 merger with LivWell, PharmaCann scaled to 50+ dispensaries and 10 cultivation/production facilities. The business is now in material operational and financial distress: 2026 has seen the Denver cultivation facility shut down (132 layoffs), the Olyphant, Pennsylvania site close (60 layoffs), and an Illinois facility close in November, alongside an ongoing SEC investigation, tenant defaults on IIP-owned properties, and a $49M asset sale to Vireo Growth that divests the company's Colorado retail footprint (closing expected Q2 2026).

Short descriptiontext

PharmaCann is a Chicago-based, vertically integrated cannabis operator founded in 2014, running 50-plus Verilife and LivWell dispensaries across eight U.S. states and wholesaling a house of brands (P3, matter., #HASH, Magnitude, Full Melt, CAM, PC Nursery) to third-party retailers via LeafLink and Leaf Trade.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cannabis cultivation, retail dispensary, medical cannabis, cannabis wholesale, cannabis concentrates
Industry3 codes
PRIMARYCRANAFAH
Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAA
Adult-Use (Recreational) Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
NAICS code2 codes
  • Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers459991
  • Health and Personal Care Retailers456
SIC code1 code
  • Retail-Drug Stores And Proprietary Stores5912
Product category
Cannabis Cultivation and Retail
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Retail Dispensary Sales
TypeTransaction Fee
Description

Direct-to-consumer sales through company-owned Verilife and LivWell dispensary locations serving medical marijuana patients and adult-use recreational customers. Revenue generated from flower, concentrates, edibles, vapes, and other cannabis products sold at retail locations across multiple states.

pharmacann.com
2B2B Wholesale
TypeTransaction Fee
Description

Wholesale distribution of branded cannabis products to other dispensaries and retail operators through LeafLink and Leaf Trade platforms. Products include flower, concentrates, edibles, and various branded merchandise.

pharmacann.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure, Technology or R&D
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1matter.
Description

Complete line of cannabis products including flower, pre-rolls, blunts, vapes, and concentrates.

pharmacann.com
+7 more records
Core offering1 text field

PharmaCann cultivates, processes, and distributes a vertically integrated portfolio of cannabis products sold through company-owned Verilife and LivWell retail dispensaries across eight U.S. states and through B2B wholesale channels on LeafLink and Leaf Trade. Its house of brands spans flower, pre-rolls, infused joints, vapes, concentrates, and edibles marketed to both medical marijuana patients and adult-use recreational consumers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over $250,000 donated to Mission Green Alliance for cannabis reform
+2 more records
Product overview1 text field

PharmaCann is a vertically integrated cannabis company operating since 2014 with operations across eight states (Illinois, New York, Ohio, Maryland, Pennsylvania, Massachusetts, Colorado, Michigan). The company offers a House of Brands consisting of wholesale cannabis product brands and two retail dispensary brands. Wholesale brands include: P3 (infused joints/blunts), matter. (complete product line), Magnitude (distillate vapes), #HASH (concentrates), LivWell (flower), Full Melt (edibles), PharmaCann Flower, CAM (premium flower), and PC Nursery (small-batch flower). The company also operates retail dispensaries under the Verilife brand (Northeast/Midwest markets) and LivWell brand (Colorado/Michigan markets). PharmaCann completed a merger with LivWell Enlightened Health in February 2022, significantly expanding its footprint.

Product and service3 records
1P3
CategoryWholesale cannabis brand – infused pre-rolls
2matter.
CategoryWholesale cannabis brand – multi-format
3Magnitude
CategoryWholesale cannabis brand – vape cartridges
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-12-01
Description

Asset purchase agreement for PharmaCann to sell 17 retail dispensaries and related assets in Colorado to Vireo Growth for approximately $49 million in subordinate voting shares. Management Services Agreement effective March 22, 2026 allows Vireo to manage PharmaCann Colorado assets until closing expected Q2 2026. Transaction represents PharmaCann's exit from Colorado market.

2CAM (California Artisanal Medicine)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-08-31
Description

Brand partnership bringing CAM premium cannabis strains to Colorado LivWell locations. PharmaCann cultivates six CAM strains including Formula 41, La Paleta, Lemon Cherry Z at Colorado facility. Exclusive provider of CAM genetics through LivWell dispensaries in Colorado.

pharmacann.com
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2021-10-12
Description

PharmaCann acquired LivWell Holdings Inc. through definitive merger agreement, completed February 28, 2022. Combined entity operates over 50 dispensaries and 10 cultivation/production facilities across 8 states. LivWell founder John Lord joined PharmaCann Board of Directors.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Philanthropic partnership supporting cannabis reform and release of individuals incarcerated for cannabis offenses. PharmaCann donated over $250,000 through round-up programs at dispensaries. Partnership expanded to New York with ongoing fundraising efforts.

5Ryne Sandberg
Strategic tierCoreTypeGTM or Marketing Partner
Description

Baseball Hall of Famer serves as celebrity spokesperson for Verilife dispensary brand. Includes in-store appearances, marketing campaigns, social media content, and special events at Illinois dispensaries.

pharmacann.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the largest multi-state cannabis operators in the U.S., operating dispensaries and cultivation across numerous states. Directly comparable to PharmaCann's vertically integrated MSO model, retail brand portfolio, and wholesale distribution strategy.

TypeDirect peer
Description

Multi-state cannabis operator with retail (Sunnyside) and wholesale brands across the U.S. Directly comparable to PharmaCann in operating model, geographic footprint, and brand portfolio approach.

TypeDirect peer
Description

Vertically integrated cannabis MSO operating Rise dispensaries and branded wholesale products. Directly comparable to PharmaCann in cultivation-retail integration and multi-state footprint including Illinois and Pennsylvania overlap.

TypeDirect peer
Description

Large multi-state cannabis operator with strong retail and cultivation presence. Directly comparable to PharmaCann's vertically integrated model, with overlap in several state markets and similar product category breadth.

TypeDirect peer
Description

Vertically integrated cannabis MSO operating across multiple U.S. states with retail and wholesale operations. Comparable to PharmaCann in business model, multi-state expansion strategy, and product portfolio approach.

TypeDirect peer
Description

Multi-state cannabis operator with vertically integrated operations and pending Canopy Growth acquisition. Comparable to PharmaCann in MSO structure and state-by-state retail-cultivation footprint.

7Columbia Care
TypeDirect peer
Description

Multi-state cannabis operator with vertically integrated cultivation and retail operations. Directly comparable to PharmaCann in business model and several overlapping state markets.

TypeDirect peer
Description

Multi-state cannabis operator currently acquiring PharmaCann's Colorado assets for $49M. Directly comparable business model; the acquisition relationship itself is highly relevant for assessing PharmaCann's asset valuations.

TypeEmerging player
Description

Colorado-anchored multi-state cannabis operator with retail and cultivation operations. Compares to PharmaCann's LivWell brand on Colorado retail footprint and is exposed to the same wholesale price collapse.

TypeEmerging player
Description

Multi-state cannabis operator with retail, wholesale, and cultivation across several U.S. states. Comparable to PharmaCann in vertically integrated operations and branded product portfolio, though smaller in scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds9 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PharmaCann

Cannabis Cultivation and Retailpharmacann.com

PharmaCann is a Chicago-based, vertically integrated cannabis operator founded in 2014, running 50-plus Verilife and LivWell dispensaries across eight U.S. states and wholesaling a house of brands (P3, matter., #HASH, Magnitude, Full Melt, CAM, PC Nursery) to third-party retailers via LeafLink and Leaf Trade.

What PharmaCann does

PharmaCann is a Chicago-headquartered, vertically integrated cannabis operator founded in 2014, running two complementary go-to-market engines: a direct-to-consumer retail dispensary network under the Verilife brand (Illinois, Maryland, Massachusetts, New York, Ohio, Pennsylvania) and the LivWell brand (Colorado, Michigan), alongside a B2B wholesale channel that distributes its house of brands—P3 (infused pre-rolls), matter. (full product line), Magnitude (distillate vapes), #HASH (concentrates), Full Melt (edibles), CAM (premium flower), PC Nursery (small-batch flower), and LivWell—to third-party dispensaries through LeafLink and Leaf Trade platforms.

Core operations span cannabis cultivation, processing, and retail across eight U.S. states, with internal production facilities including a Hamptonburgh, New York cultivation site. The company's house-of-brands architecture targets distinct price points, potency levels, and consumption formats—from premium CAM flower to the lower-potency matter.lite line for newer consumers—while a social equity program (Mission Green Alliance, round-up donations) functions as a non-product differentiator.

Revenue is generated primarily through retail transaction fees at company-owned dispensaries and wholesale distribution to third-party retailers. Following the February 2022 merger with LivWell, PharmaCann scaled to 50+ dispensaries and 10 cultivation/production facilities. The business is now in material operational and financial distress: 2026 has seen the Denver cultivation facility shut down (132 layoffs), the Olyphant, Pennsylvania site close (60 layoffs), and an Illinois facility close in November, alongside an ongoing SEC investigation, tenant defaults on IIP-owned properties, and a $49M asset sale to Vireo Growth that divests the company's Colorado retail footprint (closing expected Q2 2026).

PharmaCann firmographics

Firmographics
Name
PharmaCann
Legal name
PharmaCann Inc.
Website
https://pharmacann.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
PharmaCann is a Chicago-based, vertically integrated cannabis operator founded in 2014, running 50-plus Verilife and LivWell dispensaries across eight U.S. states and wholesaling a house of brands (P3, matter., #HASH, Magnitude, Full Melt, CAM, PC Nursery) to third-party retailers via LeafLink and Leaf Trade.
Ownership category
akta.pro rank

PharmaCann industry classification

Industry
Product category
Cannabis Cultivation and Retail
NAICS
Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers (459991), Health and Personal Care Retailers (456)
SIC
Retail-Drug Stores And Proprietary Stores (5912)
akta.pro industry
PRIMARYCRANAFAH
Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise)
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAA
Adult-Use (Recreational) Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)
SECONDARYCRANAFAB
Medical Cannabis Dispensaries
Consumer Products & Retail/Tobacco, Alcohol & Cannabis Retail/Cannabis Dispensaries (Adult-Use & Medical)

Keywords

  • Cannabis cultivation
  • Retail dispensary
  • Medical cannabis
  • Cannabis wholesale
  • Cannabis concentrates

Where PharmaCann is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Offices4 records

Markets served

PharmaCann business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

  1. Retail Dispensary Sales: Direct-to-consumer sales through company-owned Verilife and LivWell dispensary locations serving medical marijuana patients and adult-use recreational customers. Revenue generated from flower, concentrates, edibles, vapes, and other cannabis products sold at retail locations across multiple states.
  2. B2B Wholesale: Wholesale distribution of branded cannabis products to other dispensaries and retail operators through LeafLink and Leaf Trade platforms. Products include flower, concentrates, edibles, and various branded merchandise.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

PharmaCann product offering

Product offering

Core offering

PharmaCann cultivates, processes, and distributes a vertically integrated portfolio of cannabis products sold through company-owned Verilife and LivWell retail dispensaries across eight U.S. states and through B2B wholesale channels on LeafLink and Leaf Trade. Its house of brands spans flower, pre-rolls, infused joints, vapes, concentrates, and edibles marketed to both medical marijuana patients and adult-use recreational consumers.

Product overview

PharmaCann is a vertically integrated cannabis company operating since 2014 with operations across eight states (Illinois, New York, Ohio, Maryland, Pennsylvania, Massachusetts, Colorado, Michigan). The company offers a House of Brands consisting of wholesale cannabis product brands and two retail dispensary brands. Wholesale brands include: P3 (infused joints/blunts), matter. (complete product line), Magnitude (distillate vapes), #HASH (concentrates), LivWell (flower), Full Melt (edibles), PharmaCann Flower, CAM (premium flower), and PC Nursery (small-batch flower). The company also operates retail dispensaries under the Verilife brand (Northeast/Midwest markets) and LivWell brand (Colorado/Michigan markets). PharmaCann completed a merger with LivWell Enlightened Health in February 2022, significantly expanding its footprint.

Differentiator

Problem solved

Functional benefit

Brands

  • matter. Complete line of cannabis products including flower, pre-rolls, blunts, vapes, and concentrates.
  • Full Melt
  • LivWell
  • #HASH
  • P3
  • Magnitude
  • CAM (California Artisanal Medicine)
  • PC Nursery

Products and services

  • P3
  • matter.
  • Magnitude

Quantifiable outcome

  • Over $250,000 donated to Mission Green Alliance for cannabis reform
  • +2 more outcomes

Companies that use PharmaCann

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

PharmaCann technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature1 record

PharmaCann partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered major, core and flagship.

  • Vireo Growth Inc.majorStrategic or Co-development Partner · 1 December 2025Asset purchase agreement for PharmaCann to sell 17 retail dispensaries and related assets in Colorado to Vireo Growth for approximately $49 million in subordinate voting shares. Management Services Agreement effective March 22, 2026 allows Vireo to manage PharmaCann Colorado assets until closing expected Q2 2026. Transaction represents PharmaCann's exit from Colorado market.
  • CAM (California Artisanal Medicine)coreStrategic or Co-development Partner · 31 August 2023Brand partnership bringing CAM premium cannabis strains to Colorado LivWell locations. PharmaCann cultivates six CAM strains including Formula 41, La Paleta, Lemon Cherry Z at Colorado facility. Exclusive provider of CAM genetics through LivWell dispensaries in Colorado.
  • LivWell Enlightened HealthflagshipStrategic or Co-development Partner · 12 October 2021PharmaCann acquired LivWell Holdings Inc. through definitive merger agreement, completed February 28, 2022. Combined entity operates over 50 dispensaries and 10 cultivation/production facilities across 8 states. LivWell founder John Lord joined PharmaCann Board of Directors.
  • Mission Green AlliancecoreGTM or Marketing PartnerPhilanthropic partnership supporting cannabis reform and release of individuals incarcerated for cannabis offenses. PharmaCann donated over $250,000 through round-up programs at dispensaries. Partnership expanded to New York with ongoing fundraising efforts.
  • Ryne SandbergcoreGTM or Marketing PartnerBaseball Hall of Famer serves as celebrity spokesperson for Verilife dispensary brand. Includes in-store appearances, marketing campaigns, social media content, and special events at Illinois dispensaries.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

PharmaCann competitors and assessment

Company assessment

Direct peers

  • Curaleaf Holdings: One of the largest multi-state cannabis operators in the U.S., operating dispensaries and cultivation across numerous states. Directly comparable to PharmaCann's vertically integrated MSO model, retail brand portfolio, and wholesale distribution strategy.
  • Cresco Labs: Multi-state cannabis operator with retail (Sunnyside) and wholesale brands across the U.S. Directly comparable to PharmaCann in operating model, geographic footprint, and brand portfolio approach.
  • Green Thumb Industries: Vertically integrated cannabis MSO operating Rise dispensaries and branded wholesale products. Directly comparable to PharmaCann in cultivation-retail integration and multi-state footprint including Illinois and Pennsylvania overlap.
  • Trulieve Cannabis: Large multi-state cannabis operator with strong retail and cultivation presence. Directly comparable to PharmaCann's vertically integrated model, with overlap in several state markets and similar product category breadth.
  • Ayr Wellness: Vertically integrated cannabis MSO operating across multiple U.S. states with retail and wholesale operations. Comparable to PharmaCann in business model, multi-state expansion strategy, and product portfolio approach.
  • Acreage Holdings: Multi-state cannabis operator with vertically integrated operations and pending Canopy Growth acquisition. Comparable to PharmaCann in MSO structure and state-by-state retail-cultivation footprint.
  • Columbia Care: Multi-state cannabis operator with vertically integrated cultivation and retail operations. Directly comparable to PharmaCann in business model and several overlapping state markets.
  • Vireo Growth: Multi-state cannabis operator currently acquiring PharmaCann's Colorado assets for $49M. Directly comparable business model; the acquisition relationship itself is highly relevant for assessing PharmaCann's asset valuations.

Emerging players

  • Schwazze: Colorado-anchored multi-state cannabis operator with retail and cultivation operations. Compares to PharmaCann's LivWell brand on Colorado retail footprint and is exposed to the same wholesale price collapse.
  • MariMed: Multi-state cannabis operator with retail, wholesale, and cultivation across several U.S. states. Comparable to PharmaCann in vertically integrated operations and branded product portfolio, though smaller in scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

PharmaCann social profiles

Digital presence

PharmaCann financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PharmaCann leadership team

Management profile

Number of profiles

Profiles12 records

PharmaCann subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

PharmaCann funding detail

Funding detail

Funding overview

Funding rounds9 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PharmaCann M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmaCann

What does PharmaCann do?

PharmaCann cultivates, processes, and distributes a vertically integrated portfolio of cannabis products sold through company-owned Verilife and LivWell retail dispensaries across eight U.S. states and through B2B wholesale channels on LeafLink and Leaf Trade. Its house of brands spans flower, pre-rolls, infused joints, vapes, concentrates, and edibles marketed to both medical marijuana patients and adult-use recreational consumers.

Is PharmaCann a public or private company?

PharmaCann is a private company. It is classified as unknown and is currently operating.

When was PharmaCann founded?

PharmaCann was founded in 2014. It employs 51 to 100 people.

Where is PharmaCann based?

PharmaCann is headquartered in Chicago, United States, in the North America region.

How does PharmaCann make money?

Two revenue lines are on record. Retail Dispensary Sales are the primary driver. The others are B2B Wholesale.

Who are PharmaCann's main competitors?

Direct peers on record are Curaleaf Holdings, Cresco Labs, Green Thumb Industries, Trulieve Cannabis, Ayr Wellness, Acreage Holdings, Columbia Care and Vireo Growth. Emerging players are Schwazze and MariMed.

Does PharmaCann have an API?

No public API is recorded for PharmaCann.

What industry is PharmaCann in?

PharmaCann's product category is Cannabis Cultivation and Retail. Its primary akta.pro industry code is CRANAFAH, Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise), with a secondary code of CRANAFAA, Adult-Use (Recreational) Cannabis Dispensaries. Its NAICS code is 459991 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Third NewsOpus Consulting to Manage Sale of PharmaCann Maryland Assets Amid RestructuringOpus Consulting Partners was appointed receiver for PharmaCann Maryland, a leading cannabis firm, following a court request by Argent Institutional Trust Company. The firm will manage day-to-day operations and oversee a structured sale of assets, including licenses and intellectual property, with court approval for bidding procedures.PR NewswireOpus Consulting Appointed Receiver for PharmaCann Maryland Assets; Announces Structured Sale ProcessOpus Consulting was appointed receiver for PharmaCann Maryland in April 2026, overseeing operations and a structured sale of assets including licenses. Court-approved bid procedures are open, with interested parties required to sign an NDA before accessing a data room.MjbizdailyMarijuana MSO Cresco scoops up PharmaCann Pennsylvania assetsCresco Labs acquired nine Pennsylvania medical marijuana dispensaries from PharmaCann in a $50 million cash-free, debt-free deal. The purchase makes Cresco the top medical marijuana retailer and wholesaler in the state. Cresco expects the deal to be immediately accretive to revenue, margins, and cash flow.Investing.comCresco Labs acquires PharmaCann for $50 million in Pennsylvania By Investing.comCresco Labs completed its acquisition of PharmaCann Penn, LLC for $50 million, including nine operational retail medical marijuana dispensaries in Pennsylvania. The deal was paid in cash and a seller note on a cash-free, debt-free basis. Pennsylvania's medical marijuana market generated over $1.1 billion in annual sales last year.Investing.comCresco Labs acquires PharmaCann for $50 million in Pennsylvania By Investing.comCresco Labs completed its acquisition of PharmaCann Penn, LLC for $50 million, adding nine operational retail medical marijuana dispensaries in Pennsylvania. The deal was paid in cash and a seller note on a cash-free, debt-free basis, and the company expects it to be accretive to revenue, margins, and cash flow.Stock TitanCresco Labs Closes $50M Pennsylvania Dispensary AcquisitionCresco Labs closed its acquisition of PharmaCann Penn, LLC for $50 million, adding nine operational medical marijuana dispensaries in Pennsylvania. The deal makes Cresco the state's top retailer and wholesaler, with the transaction expected to be immediately accretive to revenue, margins, and cash flow.Dealroom.coGrown Rogue enters New York with $15M PharmaCann dealGrown Rogue International is acquiring PharmaCann's New York licence and assets, closing initial transactions backed by $15 million in project-based capital commitments. The deal includes an exclusivity agreement and consulting, lease, and funding arrangements to avoid shutdowns. Grown Rogue expects returns on incremental invested capital above 75%.Financial PostVireo Growth Receives Regulatory Approval and Completes Acquisition of PharmaCann Colorado Retail AssetsVireo Growth has received regulatory approval to complete its acquisition of PharmaCann's Colorado retail assets. The transaction represents a strategic move intended to strengthen Vireo's operational capabilities and market position in the cannabis sector. The integration of these assets is expected to contribute to the company's long-term organic growth.The Cool DownColorado's empty cannabis cultivation buildings could offer data centers a ready-made homeAn opinion essay proposes converting vacant or struggling indoor cannabis cultivation buildings in Colorado into data centers, leveraging existing infrastructure such as electrical capacity, climate control, and security systems. The proposal emerges as the state's cannabis industry contracts, with large Denver-area facilities operated by Green Dragon and PharmaCann having closed, while computing demand grows alongside artificial intelligence expansion. The author argues that policymakers and developers should assess shuttered grow facilities before proceeding with entirely new data center construction, though noted limitations include properties that may be too small, too specialized, or too expensive to retrofit.Shaw LocalSEA Craft takes over former PharmaCann operation in DwightSEA Craft, a Grown Rogue partner, received approval from Illinois to restart cultivation at the former PharmaCann facility in Dwight. Initial plans include four flower rooms for 5,000 square feet, with first harvest expected by September and sales in Q4 2026. The company plans to expand to 10,000 square feet and rehire former PharmaCann workers.